Timothy Price — ASN Events

Timothy Price — ASN Events

Timothy Price

Queen Elizabeth Hospital, SA, Australia

This delegate is presenting an abstract at this event.

Presentations this author is a contributor to:

First-line cetuximab with FOLFOX or FOLFIRI every 2 weeks in KRAS wild-type metastatic colorectal cancer: phase II APEC study (#17)

Indigenous patients and metastatic colorectal cancer: Results from the South Australian (SA) metastatic colorectal cancer (mCRC) registry (#6)

Christopher Hocking

PETACC6 - Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer (10545)

Colorectal Cancer